全文获取类型
收费全文 | 5447篇 |
免费 | 316篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 312篇 |
妇产科学 | 70篇 |
基础医学 | 601篇 |
口腔科学 | 110篇 |
临床医学 | 536篇 |
内科学 | 1201篇 |
皮肤病学 | 80篇 |
神经病学 | 479篇 |
特种医学 | 132篇 |
外科学 | 995篇 |
综合类 | 132篇 |
一般理论 | 3篇 |
预防医学 | 275篇 |
眼科学 | 138篇 |
药学 | 293篇 |
中国医学 | 15篇 |
肿瘤学 | 358篇 |
出版年
2023年 | 56篇 |
2022年 | 35篇 |
2021年 | 175篇 |
2020年 | 117篇 |
2019年 | 155篇 |
2018年 | 188篇 |
2017年 | 125篇 |
2016年 | 152篇 |
2015年 | 143篇 |
2014年 | 226篇 |
2013年 | 232篇 |
2012年 | 399篇 |
2011年 | 439篇 |
2010年 | 224篇 |
2009年 | 212篇 |
2008年 | 323篇 |
2007年 | 302篇 |
2006年 | 295篇 |
2005年 | 254篇 |
2004年 | 246篇 |
2003年 | 250篇 |
2002年 | 213篇 |
2001年 | 111篇 |
2000年 | 104篇 |
1999年 | 97篇 |
1998年 | 47篇 |
1997年 | 36篇 |
1996年 | 28篇 |
1995年 | 19篇 |
1994年 | 27篇 |
1993年 | 22篇 |
1992年 | 41篇 |
1991年 | 38篇 |
1990年 | 34篇 |
1989年 | 32篇 |
1988年 | 35篇 |
1987年 | 19篇 |
1986年 | 22篇 |
1985年 | 35篇 |
1984年 | 27篇 |
1983年 | 23篇 |
1982年 | 20篇 |
1981年 | 15篇 |
1980年 | 13篇 |
1979年 | 19篇 |
1978年 | 16篇 |
1977年 | 15篇 |
1976年 | 12篇 |
1974年 | 16篇 |
1971年 | 15篇 |
排序方式: 共有5778条查询结果,搜索用时 14 毫秒
81.
Paul G. Mathew 《Current pain and headache reports》2016,20(5):32
Primary and secondary headache disorders have established diagnostic criteria in the International Classification of Headache Disorders IIIb, as well as classic findings, which although not part of the formal criteria are often suggestive of a particular diagnosis. At times, headache disorders can involve unusual symptoms that lack an identifiable secondary cause. This review will discuss some of these unusual symptoms, including headache associated auditory and olfactory symptoms, as well as two case reports involving gelastic migraine and migrainous thoracalgia. 相似文献
82.
83.
84.
Maya Thomas Ajith Sivadasan Mathew Alexander Anil Kumar B. Patil 《Annals of Indian Academy of Neurology》2012,15(4):329-331
Subacute sclerosing panencephalitis (SSPE) is chronic encephalitis occurring after infection with measles virus. An 8-year-old boy presented with progressive behavioral changes, cognitive decline and myoclonic jerks, progressing to a bed bound state over 2 months. Magnetic resonance imaging (MRI) brain showed T2-weighted hyperintensities in the subcortical areas of the left occipital lobe and brachium of the inferior colliculus on both sides. EEG showed bilateral, synchronous periodic discharges. Serum/cerebrospinal fluid measles IgG titer was significantly positive. The overall features were suggestive of SSPE. MRI finding of bilateral inferior colliculus changes on MRI without significant involvement of other commonly involved areas suggests an uncommon/rare imaging pattern of SSPE. 相似文献
85.
Nicholas Murphy Nithya Ramakrishnan Bylinda Vo-Le Brittany Vo-Le Mark A. Smith Tabish Iqbal Alan C. Swann Sanjay J. Mathew Marijn Lijffijt 《Neuropsychopharmacology》2021,46(4):820
The kynurenine pathway (KP) is a strategic metabolic system that combines regulation of neuronal excitability via glutamate receptor function and neuroinflammation via other KP metabolites. This pathway has great promise in treatment of depression and suicidality. The KP modulator AV-101 (4-chlorokynurenine, 4-Cl-KYN), an oral prodrug of 7-chlorokynurenic acid (7-Cl-KYNA), an N-methyl-d-aspartate receptor (NMDAR) glycine site antagonist, and of 4-chloro-3-hydroxyanthranilic acid (4-Cl-3-HAA), a suppressor of NMDAR agonist quinolinic acid (QUIN), is a promising potential antidepressant that targets glutamate functioning via the KP. However, a recent placebo-controlled clinical trial of AV-101 in depression found negative results. This raises the question of whether AV-101 can penetrate the brain and engage the NMDAR and KP effectively. To address this problem, ten healthy US military veterans (mean age = 32.6 years ± 6.11; 1 female) completed a phase-1 randomized, double-blind, placebo-controlled, crossover study to examine dose-related effects of AV-101 (720 and 1440 mg) on NMDAR engagement measured by γ-frequency band auditory steady-state response (40 Hz ASSR) and resting EEG. Linear mixed models revealed that 1440 mg AV-101, but not 720 mg, increased 40 Hz ASSR and 40 Hz ASSR γ-inter-trial phase coherence relative to placebo. AV-101 also increased 4-Cl-KYN, 7-Cl-KYNA, 4-Cl-3-HAA, 3-HAA, and KYNA in a dose-dependent manner, without affecting KYN and QUIN. AV-101 was safe and well tolerated. These results corroborate brain target engagement of 1440 mg AV-101 in humans, consistent with blockade of interneuronal NMDAR blockade. Future studies should test higher doses of AV-101 in depression. Suicidal behavior, which has been associated with high QUIN and low KYNA, is also a potential target for AV-101.Subject terms: Biomarkers, Neurophysiology, Neuroscience 相似文献
86.
Nivedita Sharma Than Singh Tomar Arun Peter Mathew K. Chandramohan R. Preethi Rari P. Mony 《The Indian journal of surgery》2017,79(6):571-573
Aggressive angiomyxoma (AAM) is a rare mesenchymal tumour of pelvis and perineum, almost exclusively occurring in females. We are reporting a case of a 53-year-old gentleman who presented with a long standing inguinoscrotal swelling misdiagnosed as inguinal hernia, for which he underwent incomplete excision at local hospital and then was referred to our centre for completion surgery. 相似文献
87.
88.
89.
Andrew P Vanezis Mirza K Baig Ian M Mitchel Matloob Shajar Surendra K Naik Robert A Henderson Thomas Mathew 《Journal of cardiovascular magnetic resonance》2011,13(1):1-2
News from the Society for Cardiovascular Magnetic Resonance 相似文献
90.
Mathew G Wilson Navin Chandra Michael Papadakis Rory O'Hanlon Sanjay K Prasad Sanjay Sharma 《Journal of cardiovascular magnetic resonance》2011,13(1):77
Regular and prolonged exercise is associated with increased left ventricular wall thickness that can overlap with hypertrophic cardiomyopathy (HCM). Differentiating physiological from pathological hypertrophy has important implications, since HCM is the commonest cause of exercise-related sudden cardiac death in young individuals. Most deaths have been reported in intermittent ''start-stop'' sports such as football (soccer) and basketball. The theory is that individuals with HCM are unable to augment stroke volume sufficiently to meet the demands of endurance sports and are accordingly ''selected-out'' of participation in such events. We report the case of an ultra-endurance athlete with 25 years of > 50 km competitive running experience, with genetically confirmed HCM; thereby demonstrating that these can be two compatible entities. 相似文献